Haulotte Group SA (EPA:PIG)

Orchard Therapeutics Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	15.09	0.19	-15.28	7.93	-26.06
Depreciation & Amortization	7.96	14.91	2.68	17.27	17.5
Other Amortization	4.33	4.55	4.08	2.56	2.65
Loss (Gain) From Sale of Assets	-0.33	-4.74	-1.07	0.04	-1.56
Asset Writedown & Restructuring Costs	6.82	-	12.26	-	4.19
Other Operating Activities	23.59	21.01	10.73	-1.35	20.55
Change in Accounts Receivable	45.1	-6	-36.29	-	13.6
Change in Inventory	-5.25	11.51	-73.45	-	48.98
Change in Accounts Payable	-23.87	-24.13	17.81	-	-24.25
Change in Other Net Operating Assets	1.87	17.98	9.18	9.15	-21.69
Operating Cash Flow	75.31	35.27	-69.36	35.6	33.91
Operating Cash Flow Growth	113.49%	-	-	4.96%	66.17%
Capital Expenditures	-12.48	-14.32	-18.18	-35.72	-31.2
Sale of Property, Plant & Equipment	1.48	6.72	2.49	1.88	2.25
Investing Cash Flow	-11.01	-7.6	-15.69	-33.84	-28.96
Long-Term Debt Issued	1.4	15.17	119.55	23.91	5.05
Long-Term Debt Repaid	-50.02	-33	-23.18	-19.82	-14.49
Net Debt Issued (Repaid)	-48.62	-17.83	96.37	4.08	-9.44
Issuance of Common Stock	-	-	-	-	0.09
Repurchase of Common Stock	-0.04	-0.11	-0.06	-0.11	-
Common Dividends Paid	-	-	-	-	-6.49
Other Financing Activities	1.67	5.3	-0.27	-	-
Financing Cash Flow	-46.99	-12.63	89.56	3.97	-15.85
Foreign Exchange Rate Adjustments	-1.69	-6.96	-1.92	-0.83	-2.03
Net Cash Flow	15.62	8.08	2.6	4.9	-12.92
Free Cash Flow	62.83	20.95	-87.54	-0.13	2.71
Free Cash Flow Growth	199.84%	-	-	-	-
Free Cash Flow Margin	9.81%	2.76%	-14.39%	-0.03%	0.62%
Free Cash Flow Per Share	2.13	0.71	-2.97	-0.00	0.09
Levered Free Cash Flow	37.79	16.65	-104.34	-10.8	41.46
Unlevered Free Cash Flow	47.6	25.15	-101.13	-8.38	43.45
Change in Net Working Capital	-19.86	-3.33	85.85	2.82	-46.3

Updated Sep 11, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.